Rovalpituzumab [1613313-01-1]

TargetMol Chemicals

Rovalpituzumab

9

1613313-01-1

Antibody

Research Use Only

Rovalpituzumab

SDS-PAGE:95% SEC-HPLC:95%

Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3) and is utilized to synthesize antibody-active molecule conjugates (ADCs). It exhibits anticancer activity and is used in the treatment of small cell lung cancer (SCLC).

3 years

-20°C

12352203